Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment.
The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.
Full description
This study aims at establishing, in a cohort of patients with solid tumors, the state of their knowledges, given information and their financial capacities regarding access to dermo-cosmetics and aesthetic solutions, that are used in the attenuation of cancer treatments' side-effects.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
210 participants in 7 patient groups
Loading...
Central trial contact
Claire VIT; Manon VOEGELIN
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal